Schedule 13D ownership disclosure
AEVI GENOMIC MEDICINE INC
Security class unavailable · CUSIP: 00835P105
Event date: 2018-08-15
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 31.5900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-18-045357
- Form type
- SC 13D
- Filer
- Aevi Genomic Medicine, LLC
- CIK
- CIK 1138776
- Filed
- Aug 17, 2018
- Reporting period
- Aug 15, 2018
- Description
- Schedule 13D beneficial ownership